A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Phase 2 placebo‐controlled study to evaluate the safety and tolerability ofdifferent doses of EDG‐15400 in adults with heart failure with preserved ejectionfraction (HFpEF).
Epistemonikos ID: 9d0cff0b1f8c9fa679a53483735fba47786fad60
First added on: Sep 01, 2026